跳转至内容
Merck
CN

MABN849

Anti-CaBP1 Antibody, clone 11E7.1

clone 11E7.1, from mouse

别名:

Calcium-binding protein 1, CaBP1, Caldendrin

登录 查看组织和合同定价。

选择尺寸


关于此项目

UNSPSC Code:
12352203
NACRES:
NA.41
eCl@ss:
32160702
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

biological source

mouse

antibody form

purified immunoglobulin

antibody product type

primary antibodies

clone

11E7.1, monoclonal

species reactivity

mouse, human

technique(s)

immunohistochemistry: suitable (paraffin), western blot: suitable

isotype

IgG1κ

NCBI accession no.

UniProt accession no.

shipped in

wet ice

target post-translational modification

unmodified

Gene Information

human ... CABP1(9478)

General description

Calcium-binding protein 1 (UniProt Q9NZU7; also known as CaBP1, Calbrain, Caldendrin) is encoded by the CABP1 gene (Gene ID 9478) in human. Caldendrin is the founding member of the nCaBP family of neuronal Ca2+-inding proteins, members of which also include CaBP2 through CaBP8. nCaBPs and neuronal calcium sensor (NCS) family members are EF-hand-type calmodulin- (CaM-) like Ca2+-sensor proteins that play important roles in neuronal Ca2+-signaling. In addition to Caldendrin, the CABP1 gene produces three other alternative splicing isoforms, L-CaBP1/Caldendrin-S2, S-CaBP1/Caldendrin-S1, and Calbrain, with varying truncated N-terminal sequence. Caldendrin, L- and S-CaBP1 share four common EF-hands, while the Calbrain isoform contains only the third and fourth EF-hands and lacks the first two. EF-hand 1 constitutively binds Mg2+ and EF-hands 3 and 4 mediate high affinity Ca2+ binding, whereas EF-hand 2 does not bind either Mg2+ or Ca2+. In addition, Caldendrin lacks the N-myristoylation sequence present in L- and S-CaBP1 and many NCS proteins. The unique Caldendrin N-terminal sequence not found in the other spliced isoforms is bipartite in nature, composed of a highly basic proline-rich N-terminal and an acidic C-terminal part. Caldendrin and S-CaBP1 are reported to interact with the L-type voltage-gated calcium channel (VGCC) Cav1.2 via different molecular determinants, and dispaly different effects on Cav1.2 channel activity.
~40 kDa observed. 39.8 kDa (isoform Caldendrin), 25.0 kDa (Isoform L-CaBP1; Caldendrin-S2), 19.4 kDa (Isoform S-CaBP1; Caldendrin-S1), 8.14 kDa (Isoform Calbrain) calculated.

Immunogen

GST-tagged recombinant human CaBP1 internal fragment.

Application

Immunohistochemistry Analysis: An 1:250 dilution from a representative lot detected CaBP1 in human cerebellum and human retina tissue.
This Anti-CaBP1 Antibody, clone 11E7.1 is validated for use in Western Blotting, Immunohistochemistry (Paraffin) for the detection of CaBP1.

Biochem/physiol Actions

Clone 11E7.1 recognizes an internal epitope in spliced isoform Caldendrin (UniProt Q9NZU7-4). The exact location of the epitope has not been mapped. Although not confirmed by direct testing, this monoclonal antibody most likely also reacts with spliced isoform L-CaBP1 (Caldendrin-S2; UniProt Q9NZU7-1), while cross-reactivity toward isoform S-CaBP1 (Caldendrin-S1; UniProt Q9NZU7-2) and isoform Calbrain (UniProt Q9NZU7-3) is unlikely.

Physical form

Format: Purified

Analysis Note

Evaluated by Western Blotting in human brain tissue lysate.

Western Blotting Analysis: 0.5 µg/mL of this antibody detected CaBP1 in 10 µg of human brain tissue lysate.

Other Notes

Concentration: Please refer to lot specific datasheet.

未找到合适的产品?  

试试我们的产品选型工具.

存储类别

12 - Non Combustible Liquids

wgk

WGK 1

flash_point_f

Not applicable

flash_point_c

Not applicable


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

相关内容

Alzheimer’s Disease is a progressively deteriorating disease. It manifests itself with memory loss, confusion, problems with judgment, planning, concentration, and personality changes; and in it’s later stages, a decline in physical abilities. The disease’s causes, cures, and preventions are unknown; however, key proteins likely involved in the degenerative mechanism have been identified. Alzheimer’s Disease is characterized by neuronal loss, alterations in neurotransmitter systems, and the presence of neurofibrillary tangles composed of abnormally hyperphosphorylated tau proteins. A prominent feature of Alzheimer’s Disease is the formation of senile plaques in selected regions of the brain. The center of these plaques are composed mainly of fibrillary aggregates of a common, but not well understood, b amyloid peptides (Aβ). The Aβ peptides are generated from the larger amyloid-β precursor protein (APP) by the sequential action of β- and γ-secretase, and it is generally accepted that oligomeric forms of this Aβ are neurotoxic, resulting in disease progression.

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持